Selvita S.A. (FRA:787)

Market Cap	150.85M -21.5%
Revenue (ttm)	87.62M +11.8%
Net Income	-678.22K
EPS	-0.04
Shares Out	n/a
PE Ratio	n/a
Forward PE	39.20
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	2
Open	8.06
Previous Close	8.06
Day's Range	8.06 - 8.06
52-Week Range	6.18 - 11.05
Beta	n/a
RSI	27.67
Earnings Date	Mar 31, 2026

About Selvita

Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, immunology, neurology, respiratory, and ot...

• Industry: Commercial Physical and Biological Research
• Founded: 2007
• Employees: 969
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 787

Financial Performance

Financial numbers in PLN